Analyst Ratings for Supernus Pharmaceuticals Inc. (SUPN)

Updated: 2017-07-27

An average rating of Overweight has been given to Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) by analysts covering the stock. SUPN had previously received a consensus rating of Buy a month ago.

Of the 7 analysts covering the stock, 5 gave it a buy rating, 0 issued an overweight rating, 2 issued a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

SUPN was given price targets by several analysts. The most optimistic analyst gave a price target of 51, which equates to a potential upside of 24.09 percent. The most pessimistic analyst gave a price target of 40, which equates to a potential downside of -2.68 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of -7.56 percent. The average change in earnings estimates over the last 90 days is -23.79 percent. Meanwhile, fiscal year estimates have been revised downwards by -7.71 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -21.32 percent.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, while 3 analysts revised their estimates downwards. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, while 3 analysts made negative revisions to their fiscal year's estimates.

SUPN has an estimated earnings growth rate of -46.43 percent as forecasted by analysts. The PEG ratio of a stock is another value frequently studied by investors. A lower PEG ratio is favorable, as that can indicate whether the high price level of a stock is warranted by high growth. Many investors consider PEG ratios between 0 and 1 as preferrable, though it could be better to see where the ratio stands relative to peers in the industry. SUPN has a PEG ratio of -0.48.

SUPN has traded between a high of 44.95 and a low of 17.25 over the past year. The current market price is above the trailing year's low by 138.26 percent, and 8.57 percent lower than its 52-week high. SUPN has a price/earnings ratio of 22.48. Investors typically compare the P/E ratio to a company's peers in the industry. The SUPN value stock report compares SUPN to some of its peers using value stock charts. The market cap of SUPN is $2.12 billion. SUPN will post this quarters earnings in days, on 0000-00-00.